mxe002

Masumi Eto, PhD

Contact Dr. Eto

1020 Locust Street
436 JAH
Philadelphia, PA 19107

(215) 503-7891
(215) 503-2073 fax

Most Recent Peer-reviewed Publications

  1. Correction to: Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology (The Journal of Physiological Sciences, (2018), 68, 1, (1-17), 10.1007/s12576-017-0556-6)
  2. Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology
  3. Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1)
  4. Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction
  5. Remodeling of the rat distal colon in diabetes: Function and ultrastructure
  6. F-actin clustering and cell dysmotility induced by the pathological W148R missense mutation of filamin B at the actin-binding domain
  7. Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1
  8. Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells
  9. Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling
  10. Caffeine relaxes smooth muscle through actin depolymerization
  11. Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells
  12. Molecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP/cGMP-induced relaxation of gastrointestinal smooth muscle
  13. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
  14. Effects of a fluorescent myosin light chain phosphatase inhibitor on prostate cancer cells
  15. Heat shock augments angiotensin II-induced vascular contraction through increased production of reactive oxygen species
  16. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 Inhibitors
  17. Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1
  18. ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21 Cip1 up-regulation and JNK
  19. Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction
  20. Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation